PEDIATRICS Vol. 106 No. 5 November 2000, pp. 998-1005
,
,
,
From the * Child Development Center, Hasbro Children's
Hospital, Brown University School of Medicine, Providence, Rhode
Island;
Children's Hospital at Strong, University of Rochester,
Rochester, New York; § Robert Warner Rehabilitation Center, Children's
Hospital of Buffalo, State University of New York at Buffalo, Buffalo,
New York;
University of Arizona, Tucson, Arizona; ¶ University of
Texas Health Science Center, Coordinating Center for Clinical Trials,
Houston, Texas; # Children's Hospital, Ohio State University, Columbus,
Ohio; ** The Children's Hospital of Philadelphia, University of
Pennsylvania, Philadelphia, Pennsylvania; 
Children's Hospital of
Buffalo, State University of New York at Buffalo, Buffalo, New York;
and §§ Casey Eye Institute, Oregon Health Sciences University,
Portland, Oregon.
| |
ABSTRACT |
|---|
|
|
|---|
Objective. The purpose of this study was to assess the relation between neonatal retinopathy of prematurity (ROP) in very low birth weight infants and neurodevelopmental function at age 5.5 years.
Methods. Longitudinal follow-up of children occurred in 2 cohorts of the Multicenter Cryotherapy for Retinopathy of Prematurity Study. The extended natural history cohort followed 1199 survivors of <1251 g birth weight from 5 centers. The threshold randomized cohort (ThRz) followed 255 infants <1251 g from 23 centers who developed threshold ROP and who consented to cryotherapy to not more than 1 eye. At 5.5 years both cohorts had ophthalmic and acuity testing and neurodevelopmental functional status determined with the Functional Independence Measure for Children (WeeFIM).
Results. Evaluations were completed on 88.7% of the extended natural history cohort; 87% had globally normal functional skills (WeeFIM: >95). As ROP severity increased, rates of severe disability increased from 3.7% among those with no ROP, to 19.7% of those with threshold ROP. Multiple logistic regression analysis demonstrated that better functional status was associated with favorable visual acuity, favorable 2-year neurological score, absence of threshold ROP, having private health insurance, and black race. Evaluations were completed on 87.4% of the ThRz children. In each functional domain, the 134 children with favorable acuity in their better eye had fewer disabilities than did the 82 children with unfavorable acuity: self-care disability 25.4% versus 76.8%, continency disability 4.5% versus 50.0%, motor disability 5.2% versus 42.7%, and communicative-social cognitive disability 22.4% versus 65.9%, respectively.
Conclusion. Severity of neonatal ROP seems to be a marker for functional disability at age 5.5 years among very low birth weight survivors. High rates of functional limitations in multiple domains occur in children who had threshold ROP, particularly if they have unfavorable visual acuity. Key words: retinopathy of prematurity, very low birth weight, developmental outcomes, longitudinal studies, prematurity, blindness, vision disorders, developmental disabilities, functional independence.
Survival is now reported for over 70% of inborn infants
with birth weights between 750 and 1000 g and for nearly 90% of
inborn infants with weights between 1001 and 1250 g.1,2 With these increased survival rates, there is a high
level of concern about disproportionately high rates of neuromotor,
sensory, developmental, and educational disabilities.3-14
These infants are also at increased risk of developing severe retinopathy of prematurity (ROP).15 Ophthalmologists have
raised concerns that children with the most severe ROP have
disproportionately high rates of severe multiple developmental
disabilities and severe functional limitations.16 Attempts
to measure neurodevelopmental functional status in children have been
hampered by a lack of simple, inexpensive, concise instruments applicable to large-scale follow-up efforts.17 The
Functional Independence Measure for Children (WeeFIM) instrument has
been developed to meet this need.18-20 WeeFIM has been
used in over 500 children without disabilities to develop standardized
norms, and further utilized in over 700 children with motor, sensory,
genetic, and developmental disabilities.21-22
The Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Multicenter
Study was designed to evaluate the risk and benefit of transscleral
cryotherapy to treat threshold ROP, and to describe the incidence and
natural history of ROP.23-25 This large cohort offers an
opportunity to examine the relationship between severity of ROP and
neurodevelopmental functional outcomes among infants who were studied
systematically during the neonatal period and were also comprehensively
examined for both visual and functional outcomes through age 5.5 years.
The purpose of this report is: 1) to examine the relationship between
acute neonatal ROP and subsequent neurodevelopmental function at 5.5 years of age using the WeeFIM in that cohort of infants followed from
birth, and 2) to examine the spectrum of neurodevelopmental functional outcomes in self-care, continency, mobility, communicative, and social
cognitive skills among infants who developed threshold ROP.
Two Patient Cohorts
The 1208 infants surviving to 1 year of age from the 5 Natural
History Centers of the original 23-center CRYO-ROP study had their
follow-up extended through age 5.5 years. The 1199 survivors (9 deaths)
are referred to as the extended natural history cohort (Fig
1). The second cohort included all 260 infants surviving at 1 year of age who developed severe ROP (defined as
threshold; Table 1) and who were enrolled
in the 23-center randomized, controlled trial of cryotherapy for
threshold ROP.23 Of these children, 255 survived to age
5.5 years (includes an overlap of 69 infants with threshold ROP from
the extended natural history cohort). Children in both cohorts were
preterm infants who had birth weights <1251 g born between
January 1, 1986 and November 30, 1987. Infants were enrolled in the
natural history study based on survival to 28 days, their parents'
provision of informed consent, absence of eye anomalies or major
congenital malformations, and initial ophthalmologic examination by a
certified study ophthalmologist before age 49 days.23,26
Additional ophthalmological examinations at intervals of 2 weeks or
less were recorded using the international classification of ROP and
continued until final ROP outcomes were
determined.24,25,27,28 Infants with at least 1 eye that
progressed to threshold ROP, and whose parents consented to randomized
treatment of not more than 1 eye with cryotherapy, make up the
threshold randomized cohort (ThRz) group.
TABLE 1
![]()
METHODS
Top
Abstract
Methods
Results
Discussion
References

View larger version (26K):
[in a new window]
Fig. 1.
Cohorts in the CRYO-ROP 5.5-year follow-up study. One thousand two
hundred eight children from the extended natural history cohort and 260 in the randomized cohort were initially eligible for follow-up. Deaths
occurred before 5.5 years of age in 9 from the extended natural history
cohort and in 5 from the randomized cohort.
Definitions of Acute ROP Used in CRYO-ROP Multicenter Clinical
Trial
ROP Categories
Each child's ROP was categorized according to the most severe stage of active ROP reached in either eye during the neonatal period. The ROP classification categories are defined in Table 1.23,27
Assessments at Follow-Up
Complete eye examinations, including funduscopic evaluations as well as cycloplegic retinoscopy, were performed by study-certified ophthalmologists, and visual function was measured by study-certified visual acuity testers, as previously described.29,30 For this report, Teller acuity cards31,32 were used to assess visual acuity because of the number of subjects unable to complete letter recognition testing at this age. Children were exempt from formal acuity testing if the ophthalmologist and parents agreed that the child had no light perception in either eye, or if the ophthalmologist and parents agreed that visual acuity was, at best, light perception, and both eyes had total retinal detachment. Grating acuity below 6.4 cycles per degree (>1 octave below the normal range) was defined as unfavorable. Favorable vision was defined as a measurable acuity better than the unfavorable category. Ophthalmic outcomes have been reported elsewhere.33 In this report, children are classified by the vision in their better eye at age 5.5 years.
The WeeFIM instrument was administered to assess the consistent and
regular performance of the child in essential tasks of self-care,
continency, mobility, locomotion, communication, and social
cognition.34 The WeeFIM involves 18 items that describe 7 levels of independence.35 Self-care items include eating,
grooming, bathing, dressing of upper and lower body, and toileting
hygiene. Sphincter control (continency) items include bladder and bowel
management. Mobility and locomotion items include changing positions
from chairs and toilet seats, walking indoors and outdoors,
self-mobility (crawl or wheelchair), and negotiating stairs and
community distances. Communication items included receptive and
expressive use of language, whether aural or visual. Social cognitive
items include social interaction, problem solving, and memory. Each
item is scored on a 7-level ordinal scale (see Table
2
). Table 2 is a sample score sheet with accompanying polar graphic for a 5.5-year-old boy with threshold ROP, favorable visual function, and diplegic cerebral palsy. Levels 6 and 7 reflect independence, and no personal assistance by an adult is required for the child to successfully complete all components of the task on a daily basis. Levels 3, 4, and 5 reflect modified dependence; either supervision or a degree of personal assistance is required to complete the task but the child performs at least one half of the activity. Levels 1 and 2 indicate dependence, with an adult performing the majority of the tasks. Total possible WeeFIM scores range from 18 to 126. The mean score for normal 5.5-year-olds is 114.8, with a standard deviation (SD) of 9.4.21
All WeeFIM interviewers were certified to use the instrument after
participating in a 3-hour training workshop and successful completion
of model cases. Cronbach's
for the interviewers exceeded .90 with
100% of the interviewers passing 2 model cases within 4 total WeeFIM
points. This is consistent with previous reliability studies.36,37
The WeeFIM scores were used to classify each child's functional status as average if scores were within 1 SD of the mean for age (scores of >105), and as at-risk if scores were 1 to 2 SDs below the mean (scores: 96-105). The mild delays of children in the at-risk category are rarely perceived by parents and educational professionals as problematic and occur in 16% of normal children. Overall, children whose scores are within 2 SDs of the mean are globally normal (WeeFIM: >95). Some disability was the category for children with scores of 2 to 4 SDs below the mean. These scores corresponded to a WeeFIM of 77 to 95 and are termed mild/moderate disability because the child also has many developmental strengths. Children with severe disability have scores >4 SDs below the mean. These correspond to WeeFIM scores <77 and reflect a child's need for adult assistance in many skills. A WeeFIM score of 77 is equivalent to the performance of an average 2.5-year-old child.
In addition to total WeeFIM scores, self-care, continency, mobility-locomotion (motor), and communication-social cognitive domains were analyzed in children with ThRz ROP. Children with any 1-item score of <4 in self-care were considered to have some self-care disability. A score of 1, 2, or 3 on a WeeFIM item indicates that the child requires significant amounts of assistance by an adult in order for the child to complete the task. Similarly, children with any 1-item score of <4 in the other domains were considered to have some disability in that category.
Statistics
WeeFIM assessments were obtained on all children and compared
with their worst-stage ROP in either eye during infancy. Descriptive statistics included frequency distributions, and measures of central tendency. Comparisons between groups were documented using appropriate statistics including
2 and t tests.
Two separate univariate analyses were performed to obtain crude
relative risks (RRs) and corresponding 95% confidence intervals (CIs)
for a number of infant characteristics in relation to having: 1) severe
disability (WeeFIM: <77) compared with absence of severe disability
(WeeFIM:
77), and 2) any disability (WeeFIM:
95) compared with no
disability (WeeFIM: >95).
Based on the univariate analyses and adjusting for multicollinearity among study variables, the 5-center extended natural history cohort data were used to examine the effects of the most significant variables identified in predicting WeeFIM outcome. This multiple regression model used total WeeFIM scores as a continuous dependent variable and both sociodemographic factors and biomedical factors as independent variables. The sociodemographic variables in these analyses included mother's race, gender, outborn status (ie, infant born in a hospital not providing neonatal intensive care), private health insurance (ie, any insurance other than Medicaid or self-pay), and highest educational level achieved by the head of household. In the regression, the dichotomy between high and low educational status was chosen as high school completion for the head of the household. The biomedical variables in these analyses included gestational age at birth, plurality (singleton vs multiple birth), small for gestational age (ie, birth weight less than the 10th percentile), having an abnormal 2-year neurological disability score (ie, recurrent seizures, microcephaly, or shunted hydrocephalus), and visual status defined as favorable if at least 1 eye had favorable Teller acuity at age 5.5 years.
| |
RESULTS |
|---|
|
|
|---|
There were 1199 survivors from the 5-Center Extended Natural History Cohort, and 1063 (88.7%) were assessed at age 5.5 years, including 66 ThRz. Among the 255 children surviving to 5.5 years who were ThRz for treatment of their ROP from all 23 centers, 223 (87.5%) completed 5.5-year follow-up examination (Fig 1).
Figure 2 demonstrates the relationship between ROP status and WeeFIM status in the 5-center extended natural history cohort. With more severe ROP, there is a lower percentage of children who are globally functionally normal (WeeFIM: >95), from 92% in no ROP to 76% in ThRz (P < .01). Similarly, with more severe ROP, severe disability (WeeFIM: <77) is more frequent and involves 3.7% of children with no ROP, but 19.7% of the children with ThRz ROP (P < .01).
|
The first univariate analysis was performed to obtain crude relative
risk (RR) for study variables and risk of severe disability (WeeFIM:
<77) compared with freedom from severe disability (WeeFIM:
77)
(Table 3). Risks for severe disability
included abnormal neurological score, ThRz ROP, any ROP, gestational
age <27 weeks, birth weight <750 g, and absence of private health insurance. Protective factors from risk of severe disability included favorable 5.5-year Teller visual acuity status and black race.
|
A second univariate analyses examined the study variables' effects on
the risk of any disability (WeeFIM:
95) compared with no disability
(WeeFIM: >95). Abnormal neurological score at 2 years (RR: 4.41; 95%
CI: 3.15-6.16), ThRz ROP (RR: 2.07; 95% CI: 1.31-3.27), any ROP (RR:
1.76; 95% CI: 1.19-2.60), and more immaturity (gestational age <27
weeks; RR: 1.43; 95% CI: 1.03-1.98) were significantly predictive of
some disability. Favorable 5.5-year Teller visual acuity status (RR:
.12; 95% CI: .09-.15), black race (RR: .40; 95% CI: .25-.66), and
inborn status (RR: .67; 95% CI: .46-.96) were apparently protective
factors that predicted a lower probability of disability (WeeFIM:
>95).
Table 4 shows the predictors of WeeFIM scores as a continuous dependent variable in a multivariate regression model. Favorable 5.5-year Teller visual acuity had the greatest predictive effect on functional status as measured by higher WeeFIM scores (P < .001). With adjustment for favorable vision, the other significant predictors in order of their magnitude of the regression coefficients were absence of threshold ROP, normal 2-year neurological score, maternal black race, and higher income as reflected by private health insurance (P < .001).
|
Noting the frequency of functional limitation in the threshold infants, the distribution of WeeFIM scores in the larger group of all ThRz infants from the CRYO-ROP study was examined. Of the 216 ThRz children evaluated with both Teller acuity and WeeFIM assessments, 82 had unfavorable acuity and 134 had favorable acuity in their better eye. Among children with favorable acuity despite ThRz ROP, the overwhelming majority (91%) were globally functionally normal with WeeFIM scores >95. Of the children with unfavorable acuity status (ie, children effectively blind), 55% had severe disabilities (WeeFIM: <77), ie, children were blind and had self-care, continency, mobility-locomotion (motor), and/or communicative-social cognitive limitations. Despite unfavorable Teller acuity status, 34% of the ThRz from all centers had globally normal WeeFIM outcomes (WeeFIM: >95).
Figure 3 shows the relationship between favorable and unfavorable visual acuity in the ThRz group and having some disability in the WeeFIM domains of self-care, continency, mobility-locomotion (motor), and communicative-social cognition areas. Among the 134 children with ThRz ROP and favorable visual acuity status at age 5.5 years, 25.4% had self-care disability, 4.5% had continency disability, 5.2% had mobility-locomotion (motor) disability, and 22.4% had communicative-social cognitive disability. In contrast, among the 82 children with unfavorable visual acuity status, self-care disability occurred in 76.8%, continency disability occurred in 50.0%, motor disability occurred in 42.7%, and communicative-social cognitive disabilities occurred in 65.9%. For all the tasks, children with unfavorable visual acuity status had much higher disability rates (P < .001).
|
| |
DISCUSSION |
|---|
|
|
|---|
Our study demonstrates that there are high rates of disability in children of very low birth weight status who develop threshold ROP and subsequently have unfavorable visual outcomes. These children are multiply disabled and have functional limitations in self-care, continency, mobility-locomotion (motor), communicative, and social cognitive skills. Historic studies of very low birth weight preterm survivors performed before 1965 by Hess,38 Knobloch et al,39 Lubchenco et al,40,41 Drillien,42,43 Fledelius,44 and McCormick and colleagues,45 demonstrated rates of severe ROP causing blindness in 2% to 11% of survivors. Fifty percent of these blind children were multiply disabled, which is similar to our results.
Previous regional epidemiologic studies in Canada, New Zealand, The Netherlands, Denmark, Sweden, England, and Australia have involved fewer than 70 children with severe ROP.46-55 Recent studies in Victoria, Australia; Perth, Australia; Alberta, Canada; and San Francisco, California have examined trends in rates of motor, cognitive, and sensory disabilities in children with birth weights of <1000 to 1251 g.7,8,46,56 Rates of blindness ranged from 1% to 7%, while rates of cerebral palsy ranged from 6% to 17%, and rates of cognitive disability ranged from 7% to 25%. Because of various definitions of disability and nonuniformity in reporting combinations of disabilities, it is difficult to determine the impact of severe ROP on multiple disabilities in these studies. More recently, Jacobson et al52 used the Swedish registry for visual impairment for the years 1980 to 1990 to evaluate 29 children with stage 5 ROP and total blindness. Significant neurodevelopmental disabilities including cerebral palsy, mental retardation, and autism were present in 76% of children.16
The strengths of our study include the systematic adherence to the diagnosis, staging, and tracking of ROP, and high follow-up rates. We were not able to relate these findings to degrees of intraventricular hemorrhage or parenchymal brain injury because intracranial hemorrhage data were not available.57 Data on periventricular leukomalacia are also known to be useful in predicting outcomes but were not available to this study.57-61 The finding that black race was a protective factor for disability was unexpected and warrants further investigation. Because race effect was not an a priori hypothesis in this study, we consider the observation to be hypothesis-generating because it may be difficult to separate race effect from known reduction in rates of threshold ROP among black infants.62
In our study, factors that lead to severe ROP seem to have an adverse impact on brain systems involved in self-care, continency, mobility-locomotion, and communicative-social cognition functional skills. This is also supported by our finding that children with abnormal neurological status at age 2 years have significantly lower WeeFIM scores at age 5.5 years.
We have demonstrated that ROP is a marker for being at risk for severe functional disability, and poor vision after threshold ROP increases the risk for severe disability. It is tempting to conclude that the use of cryotherapy to preserve vision may reduce severe disability rates. However, ROP nonresponsive to cryotherapy may indicate children with brain injury. Additionally, children with visual impairment are not all severely functionally limited on the WeeFIM. In our study 34% of children with unfavorable visual acuity had globally normal WeeFIM scores (WeeFIM: >95). Unquestionably, those children who retained vision in at least 1 eye functioned much more independently. Our data do not allow us to categorically state that rescuing vision in children with severe ROP guarantees better functional status. There are many confounding variables that impact on functional competencies at kindergarten entry, including the degree of initial brain injury, chronic childhood illness, family resources, and quality early childhood experiences (eg, early intervention, Head Start, preschool). In contrast, retaining vision in at least 1 eye is strongly associated with better functional status and efforts to increase visual status should be pursued. In addition, comprehensive developmental interventions are required to optimize long-term outcomes and support families in the care of children who are born very prematurely.6,63-66
| |
ACKNOWLEDGMENTS |
|---|
This research was supported by Cooperative Agreement EYO5874 from the US Public Health Service, National Institutes of Health, National Eye Institute.
All of the marks associated with WeeFIM belong to the Uniform Data System for Medical Rehabilitation, a division of UB Foundation Activities.
The Center for Functional Assessment Research of UDSMR-SUNY at Buffalo provided manuals and training tapes.
Maryann Kihl, Judy daSilva, J. DeRobbio, H. Ripstein, and Michelle Tremont assisted in manuscript preparation. Germaine Buck, PhD; Lewis Rubin, MD; Betty Vohr, MD; and Dennis Hogan, PhD, provided critical feedback.
We gratefully acknowledge the efforts of the many site coordinators and investigators and participating families and children.
This manuscript is dedicated to Dr Robert E. Cooke for his lifelong dedication to the prevention of developmental disabilities and advocacy for children and families with multiple disabilities.
| |
FOOTNOTES |
|---|
|| A complete list of the members of the Cryotherapy for Retinopathy of Prematurity Cooperative Group appears on pages 420-421 of reference 33.
Dr Msall is Medical Director and Scientific Advisory Chair of the WeeFIM-UDS, a not-for-profit organization within the Center for Functional Assessment Research, State University of New York at Buffalo. He has no financial interest in the WeeFIM assessment tool.
Dr Dobson receives royalties from the sale of the Teller acuity cards.
Received for publication Sept 21, 1999; accepted Mar 17, 2000.
Reprint requests to (E.A.P.) CRYO-ROP Study Headquarters, Oregon Health Sciences University, Casey Eye Institute, 3375 SW Terwilliger Blvd, Portland, OR 92701-4197. E-mail: palmere{at}ohsu.edu
| |
ABBREVIATIONS |
|---|
ROP, retinopathy of prematurity; WeeFIM, Functional Independence Measure for Children; CRYO-ROP, cryotherapy for retinopathy of prematurity; ThRz, threshold randomized cohort; SD, standard deviation; RR, relative risk; CI, confidence interval.
| |
REFERENCES |
|---|
|
|
|---|
a matter of definition.
Acta Paediatr
1995;
84:1160-1164 [Medline]
structure and function.
Arch Ophthalmol
1990;
108:1408-1416 [Abstract]
structure and function.
Arch Ophthalmol
1993;
111:339-344 [Abstract]
28 weeks gestation or
1000 g birth weight.
J Pediatr Child Health
1990;
26:205-208 This article has been cited by other articles:
![]() |
B. Schmidt, R. S. Roberts, P. Davis, L. W. Doyle, K. J. Barrington, A. Ohlsson, A. Solimano, W. Tin, and the Caffeine for Apnea of Prematurity Trial Group Long-Term Effects of Caffeine Therapy for Apnea of Prematurity N. Engl. J. Med., November 8, 2007; 357(19): 1893 - 1902. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Gianni, O. Picciolini, C. Vegni, L. Gardon, M. Fumagalli, and F. Mosca Twelve-Month Neurofunctional Assessment and Cognitive Performance at 36 Months of Age in Extremely Low Birth Weight Infants Pediatrics, November 1, 2007; 120(5): 1012 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. N. Wong and V. C. N. Wong Functional Independence Measure for Children: A Comparison of Chinese and Japanese Children Neurorehabil Neural Repair, January 1, 2007; 21(1): 91 - 96. [Abstract] [PDF] |
||||
![]() |
V. Tommiska, K. Heinonen, L. Lehtonen, M. Renlund, T. Saarela, O. Tammela, M. Virtanen, and V. Fellman No Improvement in Outcome of Nationwide Extremely Low Birth Weight Infant Populations Between 1996-1997 and 1999-2000 Pediatrics, January 1, 2007; 119(1): 29 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Msall The Limits of Viability and the Uncertainty of Neuroprotection: Challenges in Optimizing Outcomes in Extreme Prematurity Pediatrics, January 1, 2007; 119(1): 158 - 160. [Full Text] [PDF] |
||||
![]() |
L. Romantseva and M. E Msall Advances in Understanding Cerebral Palsy Syndromes After Prematurity NeoReviews, November 1, 2006; 7(11): e575 - e585. [Full Text] [PDF] |
||||
![]() |
C. Lofqvist, E. Engstrom, J. Sigurdsson, A.-L. Hard, A. Niklasson, U. Ewald, G. Holmstrom, L. E. H. Smith, and A. Hellstrom Postnatal head growth deficit among premature infants parallels retinopathy of prematurity and insulin-like growth factor-1 deficit. Pediatrics, June 1, 2006; 117(6): 1930 - 1938. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Msall The retina as a window to the brain in vulnerable neonates. Pediatrics, June 1, 2006; 117(6): 2287 - 2289. [Full Text] [PDF] |
||||
![]() |
S. R. Hintz, D. E. Kendrick, B. R. Vohr, W. K. Poole, R. D. Higgins, and for the National Institute of Child Health and Hum Changes in Neurodevelopmental Outcomes at 18 to 22 Months' Corrected Age Among Infants of Less Than 25 Weeks' Gestational Age Born in 1993-1999 Pediatrics, June 1, 2005; 115(6): 1645 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Msall Developmental Vulnerability and Resilience in Extremely Preterm Infants JAMA, November 17, 2004; 292(19): 2399 - 2401. [Full Text] [PDF] |
||||
![]() |
CRYO-ROP Cooperative Group Health-Related Quality of Life at Age 10 Years in Very Low-Birth-Weight Children With and Without Threshold Retinopathy of Prematurity Arch Ophthalmol, November 1, 2004; 122(11): 1659 - 1666. [Abstract] [Full Text] [PDF] |
||||
![]() |
Follow-up Care of High-Risk Infants Pediatrics, November 1, 2004; 114(5/S1): 1377 - 1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Msall, D. L. Phelps, R. J. Hardy, V. Dobson, G. E. Quinn, C. G. Summers, M. R. Tremont, and for the Cryotherapy for Retinopathy of Prematurity Educational and Social Competencies at 8 Years in Children With Threshold Retinopathy of Prematurity in the CRYO-ROP Multicenter Study Pediatrics, April 1, 2004; 113(4): 790 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
Early Treatment for Retinopathy of Prematurity Coo Revised Indications for the Treatment of Retinopathy of Prematurity: Results of the Early Treatment for Retinopathy of Prematurity Randomized Trial Arch Ophthalmol, December 1, 2003; 121(12): 1684 - 1694. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Tin and E. Hey The Medical Use of Oxygen: A Century of Research in Animals and Humans NeoReviews, December 1, 2003; 4(12): e349 - 355. [Full Text] [PDF] |
||||
![]() |
B. Schmidt, E. V. Asztalos, R. S. Roberts, C. M. T. Robertson, R. S. Sauve, M. F. Whitfield, and for the Trial of Indomethacin Prophylaxis in Prete Impact of Bronchopulmonary Dysplasia, Brain Injury, and Severe Retinopathy on the Outcome of Extremely Low-Birth-Weight Infants at 18 Months: Results From the Trial of Indomethacin Prophylaxis in Preterms JAMA, March 5, 2003; 289(9): 1124 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
Cryotherapy for Retinopathy of Prematurity Coopera Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: Ophthalmological Outcomes at 10 Years Arch Ophthalmol, August 1, 2001; 119(8): 1110 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Phelps Retinopathy of Prematurity: Clinical Trials NeoReviews, July 1, 2001; 2(7): e167 - 173. [Full Text] [PDF] |
||||
| ||||||||||||||||